Paper Tools Add to my Library Share How would you like to share? Facebook Twitter LinkedIn Back to the Top
Farlow MR, Lilly ML, . Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years. BMC Geriatr. 2005;5:3. PubMed. Recommends Please login to recommend the paper. Comments No Available Comments Make a Comment To make a comment you must login or register.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.